Manlio Mencoboni

2.5k total citations
79 papers, 1.4k citations indexed

About

Manlio Mencoboni is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Manlio Mencoboni has authored 79 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Manlio Mencoboni's work include Occupational and environmental lung diseases (23 papers), Lung Cancer Treatments and Mutations (18 papers) and Pleural and Pulmonary Diseases (13 papers). Manlio Mencoboni is often cited by papers focused on Occupational and environmental lung diseases (23 papers), Lung Cancer Treatments and Mutations (18 papers) and Pleural and Pulmonary Diseases (13 papers). Manlio Mencoboni collaborates with scholars based in Italy, France and Netherlands. Manlio Mencoboni's co-authors include Giovanni Luca Ceresoli, I Pannacciulli, Antonio Chella, Marcello Ceppi, Mario Botta, Federica Grosso, Armando Santoro, B. Castagneto, Letizia Gianoncelli and Paolo Andrea Zucali and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Manlio Mencoboni

79 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manlio Mencoboni Italy	20	956	381	149	116	106	79	1.4k
M. Paganuzzi Italy	16	518 0.5×	331 0.9×	257 1.7×	59 0.5×	115 1.1×	38	992
Mary Hesdorffer United States	15	1.2k 1.2×	343 0.9×	318 2.1×	106 0.9×	179 1.7×	27	1.5k
A Vivaldi Italy	18	392 0.4×	361 0.9×	280 1.9×	53 0.5×	132 1.2×	33	1.2k
Manabu Yasuda Japan	21	521 0.5×	578 1.5×	397 2.7×	118 1.0×	155 1.5×	91	1.4k
Munehisa Imaizumi Japan	17	458 0.5×	380 1.0×	247 1.7×	67 0.6×	164 1.5×	41	968
William H. Liggett United States	10	411 0.4×	588 1.5×	522 3.5×	45 0.4×	118 1.1×	16	1.2k
P. Dohrmann Germany	14	301 0.3×	185 0.5×	182 1.2×	53 0.5×	193 1.8×	46	761
Italia Grenga United States	20	337 0.4×	1.1k 2.9×	326 2.2×	96 0.8×	157 1.5×	43	1.6k
Ewa Kalinka‐Warzocha Poland	18	363 0.4×	504 1.3×	160 1.1×	69 0.6×	81 0.8×	91	944
Juan J. Grau Spain	21	615 0.6×	847 2.2×	278 1.9×	49 0.4×	438 4.1×	60	1.7k

Countries citing papers authored by Manlio Mencoboni

Since Specialization

Citations

This map shows the geographic impact of Manlio Mencoboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manlio Mencoboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manlio Mencoboni more than expected).

Fields of papers citing papers by Manlio Mencoboni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manlio Mencoboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manlio Mencoboni. The network helps show where Manlio Mencoboni may publish in the future.

Co-authorship network of co-authors of Manlio Mencoboni

This figure shows the co-authorship network connecting the top 25 collaborators of Manlio Mencoboni. A scholar is included among the top collaborators of Manlio Mencoboni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manlio Mencoboni. Manlio Mencoboni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mencoboni, Manlio, Vincenzo Fontana, Alessandro Raso, et al.. (2022). Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy. Current Oncology. 29(5). 3364–3374. 4 indexed citations

Mencoboni, Manlio, Marcello Ceppi, Marco Bruzzone, et al.. (2021). Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis. Cancers. 13(6). 1388–1388. 26 indexed citations

Lai, Eleonora, Marco Puzzoni, Pina Ziranu, et al.. (2021). Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study. Clinical Colorectal Cancer. 20(4). e253–e262. 2 indexed citations

Pujol, Jean-Louis, Amandine Coffy, Andrea Camerini, et al.. (2019). An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer. PLoS ONE. 14(8). e0220988–e0220988. 19 indexed citations

Ceresoli, Giovanni Luca, Joachim G.J.V. Aerts, Rafał Dziadziuszko, et al.. (2019). Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial. The Lancet Oncology. 20(12). 1702–1709. 107 indexed citations

Pasello, Giulia, Giulia Zago, Francesca Lunardi, et al.. (2018). Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical–pathological features and intratumor heterogeneity over time. Annals of Oncology. 29(5). 1258–1265. 72 indexed citations

Camerini, Andrea, Giuseppe Luigi Banna, Saverio Cinieri, et al.. (2018). Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis. Clinical & Translational Oncology. 21(6). 790–795. 22 indexed citations

Mencoboni, Manlio, Rosangela Filiberti, Federica Grosso, et al.. (2017). Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma. Oncology Research and Treatment. 40(6). 364–369. 3 indexed citations

Grosso, Federica, Rodryg Ramlau, S. Cedrés, et al.. (2017). OA22.01 STELLAR - Interim Results of a Phase 2 Trial of TTFields with Chemotherapy for First Line Treatment of Malignant Mesothelioma. Journal of Thoracic Oncology. 12(1). S329–S329. 2 indexed citations

10.

Ceresoli, Giovanni Luca, Federica Grosso, Paolo Andrea Zucali, et al.. (2014). Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey. British Journal of Cancer. 111(2). 220–226. 29 indexed citations

11.

Ceresoli, Giovanni Luca, Paolo Andrea Zucali, Manlio Mencoboni, et al.. (2013). Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma. British Journal of Cancer. 109(3). 552–558. 68 indexed citations

12.

Boni, C., Marcello Tiseo, Luca Boni, et al.. (2012). Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). British Journal of Cancer. 106(4). 658–665. 19 indexed citations

13.

Mencoboni, Manlio, Grillo Ruggieri F, Felice Scasso, et al.. (2010). Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy. European Journal of Cancer Care. 20(4). 503–507. 2 indexed citations

14.

Gemignani, Federica, Monica Neri, Fabio Bottari, et al.. (2009). Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 671(1-2). 76–83. 16 indexed citations

15.

Landi, Stefano, Federica Gemignani, Monica Neri, et al.. (2007). Polymorphisms of glutathione‐S‐transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. International Journal of Cancer. 120(12). 2739–2743. 46 indexed citations

16.

Castagneto, B., Mario Botta, Enrico Aitini, et al.. (2007). Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Annals of Oncology. 19(2). 370–373. 102 indexed citations

17.

Schenone, Eva, et al.. (2002). Dexamethazone-induced Acute Tumor Lysis Syndrome in a T-cell Malignant Lymphoma. Leukemia & lymphoma. 43(5). 1129–1132. 20 indexed citations

18.

Vannozzi, Maria O., Maurizio Viale, Giuseppe Castello, et al.. (1997). Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion. Annals of Oncology. 8(4). 385–391. 12 indexed citations

19.

Ballarino, Paola, et al.. (1996). Interferon-α Inhibits CFU-GM Mobilization Following Chemotherapy and G-CSF Administration. Journal of Interferon & Cytokine Research. 16(11). 953–956. 1 indexed citations

20.

Mencoboni, Manlio, et al.. (1990). Toxicity of Vidarabine on Hemopoietic Progenitor Cells in Mice. Chemotherapy. 36(3). 240–244. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact